Esperion Therapeutics
ESPR
#6664
Rank
A$1.19 B
Marketcap
A$4.62
Share price
0.00%
Change (1 day)
23.62%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio on November 10, 2026 (TTM) : 1.96

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -2.66. At the end of 2023 the company had a P/S ratio of 2.92.

P/S ratio history for Esperion Therapeutics from 2013 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.62 33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
6.13 212.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
2.33 19.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
19.5 897.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 266.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.25 65.94%๐Ÿ‡บ๐Ÿ‡ธ USA